A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 188 shares of HAE stock, worth $14,553. This represents 0.0% of its overall portfolio holdings.

Number of Shares
188
Previous 142 32.39%
Holding current value
$14,553
Previous $11.7 Million 28.63%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.45 - $91.58 $3,332 - $4,212
46 Added 32.39%
188 $15.1 Million
Q1 2024

May 13, 2024

BUY
$71.24 - $85.35 $10,116 - $12,119
142 New
142 $12.1 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.97B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Annis Gardner Whiting Capital Advisors, LLC Portfolio

Follow Annis Gardner Whiting Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Annis Gardner Whiting Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Annis Gardner Whiting Capital Advisors, LLC with notifications on news.